华安创新医药锐选量化股票发起式A(014820)资产负债表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
资产 |
银行存款 |
- |
- |
- |
854,893.74 |
结算备付金 |
3,010.59 |
67,455.18 |
21,862.50 |
80,342.60 |
存出保证金 |
1,398.88 |
3,615.22 |
3,155.43 |
5,598.08 |
交易性金融资产 |
9,142,718.41 |
9,102,112.91 |
12,485,795.42 |
12,620,418.33 |
其中:股票投资 |
9,040,807.29 |
9,102,112.91 |
12,485,795.42 |
12,615,517.92 |
债券投资 |
101,911.12 |
- |
- |
4,900.41 |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
- |
210,661.32 |
34,797.37 |
381,113.28 |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
4,416.00 |
- |
- |
应收申购款 |
5,569.25 |
1,140.27 |
2,095.44 |
6,963.04 |
其他资产 |
- |
- |
- |
- |
资产总计 |
9,909,249.16 |
9,932,215.88 |
13,298,819.08 |
13,949,329.07 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
3.77 |
- |
0.35 |
401,683.28 |
应付赎回款 |
10,105.79 |
3,557.73 |
1,564.45 |
3,250.31 |
应付管理人报酬 |
10,328.97 |
10,743.55 |
13,696.55 |
16,636.58 |
应付托管费 |
1,721.51 |
1,790.58 |
2,282.74 |
2,772.74 |
应付销售服务费 |
667.75 |
1,034.84 |
1,204.10 |
1,071.76 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
16,174.26 |
40,065.43 |
89,521.84 |
145,551.03 |
负债合计 |
39,002.05 |
57,192.13 |
108,270.03 |
570,965.70 |
所有者权益 |
实收基金 |
14,296,488.37 |
15,450,596.89 |
15,757,546.58 |
14,857,989.58 |
未分配利润 |
-4,426,241.26 |
-5,575,573.14 |
-2,566,997.53 |
-1,479,626.21 |
所有者权益合计 |
9,870,247.11 |
9,875,023.75 |
13,190,549.05 |
13,378,363.37 |
负债及所有者权益总计 |
9,909,249.16 |
9,932,215.88 |
13,298,819.08 |
13,949,329.07 |